Reference Source

SICOR Societa' Italiana Corticosteroidi s.r.l. · 66-66 · ITALY

For SICOR Societa' Italiana Corticosteroidi s.r.l. · 66-66 · ITALY, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is ITALY; product is Atenolol | Terazosin HCl | Labetalol HCL | Metoprolol Tartrate; product code is 60 X - S 17 Atenolol (Anti-Adrenergic), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 10 Terazosin Hydrochloride (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 39 Labetalol Hydrochloride (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 44 Metoprolol Tartrate (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Via Enrico Fermi 20/26 , Settimo Milanese, Milan ITALY, verified against its source on 2026-09-16.

Firm
SICOR Societa' Italiana Corticosteroidi s.r.l. verified
Import alert
66-66
Import alert name
"APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
Country
ITALY verified
Address
Via Enrico Fermi 20/26 , Settimo Milanese, Milan ITALY verified
Date published
09/30/2009 verified
Product code
60 X - S 17 Atenolol (Anti-Adrenergic), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 10 Terazosin Hydrochloride (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 39 Labetalol Hydrochloride (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 44 Metoprolol Tartrate (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf each item verified
Product
Atenolol | Terazosin HCl | Labetalol HCL | Metoprolol Tartrate each item verified
FDA notes
11/2/2000 | 11/2/2000 | 11/2/2000 | 11/2/2000 each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

SICOR Societa' Italiana Corticosteroidi s.r.l. Date Published : 09/30/2009 Via Enrico Fermi 20/26 , Settimo Milanese, Milan ITALY 60 X - S 17 Atenolol (Anti-Adrenergic), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Atenolol Notes: 11/2/2000 62 O - S 10 Terazosin Hydrochloride (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Terazosin HCl Notes: 11/2/2000 62 O - S 39 Labetalol Hydrochloride (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Labetalol HCL Notes: 11/2/2000 62 O - S 44 Metoprolol Tartrate (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Metoprolol Tartrate Notes: 11/2/2000

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.